SSGI (OTCMKTS:VICP) Stock Price Up 18.1% - Still a Buy?

Key Points

• SSGI Inc.'s stock price increased by 18.1% on Thursday, reaching a last traded price of $1.50 after previously closing at $1.27.
• The company focuses on the development of VICAPSYN and VYBRIN, products aimed at enhancing transplantation therapies and preventing post-surgical adhesions.
• With a market capitalization of $48.56 million and a high beta of 4.27, SSGI showcases a significant degree of volatility in its stock performance.

SSGI Inc. (OTCMKTS:VICP - )'s stock price rose 18.1% on Thursday . The company traded as high as $1.75 and last traded at $1.50. Approximately 835 shares were traded during mid-day trading, The stock had previously closed at $1.27.

SSGI Stock Performance

The business's 50-day moving average is $1.76 and its two-hundred day moving average is $1.77. The stock has a market capitalization of $48.56 million, a PE ratio of -37.50 and a beta of 4.27.

About SSGI

Vicapsys Life Sciences, Inc focuses on the development and commercialization of VICAPSYN, a proprietary product. The company's product is applied to transplantation therapies and related stem-cell applications in the transplantation field. It also develops VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.